UBP-302

UBP-302 is a highly selective Kainate receptor antagonist used in the study of many neurological processes. It is active at micromolar concentration within an in vitro preparation and specifically targets the GluR5 subunit of the receptor. It has only been recently made commercially available through such companies as Tocris.

UPB-302 is useful in the study of neuronal up-states.